4.12
Schlusskurs vom Vortag:
$4.40
Offen:
$4.36
24-Stunden-Volumen:
324.11K
Relative Volume:
1.31
Marktkapitalisierung:
$147.70M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-10.82%
1M Leistung:
-0.24%
6M Leistung:
-10.24%
1J Leistung:
+0.00%
Bioage Labs Inc Stock (BIOA) Company Profile
Firmenname
Bioage Labs Inc
Sektor
Telefon
510-806-1445
Adresse
1445A SOUTH 50TH STREET, RICHMOND
Vergleichen Sie BIOA mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
BIOA
Bioage Labs Inc
|
4.12 | 157.74M | 0 | 0 | 0 | 0.00 |
![]()
ZTS
Zoetis Inc
|
147.38 | 64.91B | 9.29B | 2.52B | 2.28B | 5.57 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.16 | 43.33B | 30.08B | 710.16M | 4.45B | 0.2182 |
![]()
HLN
Haleon Plc Adr
|
9.66 | 42.36B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.38 | 17.72B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
UTHR
United Therapeutics Corp
|
294.28 | 12.42B | 2.99B | 1.21B | 1.13B | 25.06 |
Bioage Labs Inc Stock (BIOA) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-02-28 | Eingeleitet | William Blair | Mkt Perform |
2024-12-10 | Herabstufung | Morgan Stanley | Overweight → Underweight |
2024-12-09 | Herabstufung | Citigroup | Buy → Neutral |
2024-12-09 | Herabstufung | Jefferies | Buy → Hold |
2024-10-21 | Eingeleitet | Citigroup | Buy |
2024-10-21 | Eingeleitet | Jefferies | Buy |
2024-10-21 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Bioage Labs Inc Aktie (BIOA) Neueste Nachrichten
BioAge Labs Requests to Dismiss Class Action Filed by Investors - TradingView
BioAge (BIOA) to Analyze Over 17,000 Biobank Samples for Drug Discovery - MSN
Published on: 2025-07-29 06:11:56 - beatles.ru
Price Channel Expanding on BioAge Labs Inc.’s ChartAccurate Buy Point for Momentum Stocks Detected - beatles.ru
Published on: 2025-07-29 09:16:13 - metal.it
Can BioAge Labs Inc. Bounce Back From Weekly LowWeekly Top Gainers Forecast Watchlist Released - metal.it
Will BioAge Labs Inc. Benefit From Sector TailwindsReal Time Stock Movement Analysis Indicates Breakout - metal.it
Should I hold or sell BioAge Labs Inc. stock in 2025Capitalize on proven investment strategies - jammulinksnews.com
Competitive Positioning of BioAge Labs Inc.: Is It Leading or LaggingLow Risk Entry Points - metal.it
What is BioAge Labs Inc. company’s growth strategyPhenomenal capital gains - jammulinksnews.com
How strong is BioAge Labs Inc. company’s balance sheetInvest confidently with data-backed picks - jammulinksnews.com
What catalysts could drive BioAge Labs Inc. stock higher in 2025Explosive wealth accumulation - jammulinksnews.com
How does BioAge Labs Inc. compare to its industry peersGet exclusive access to premium stock research - jammulinksnews.com
What are the latest earnings results for BioAge Labs Inc.Phenomenal capital gains - jammulinksnews.com
Is BioAge Labs Inc. a growth stock or a value stockRapidly expanding wealth - jammulinksnews.com
What analysts say about BioAge Labs Inc. stockOutstanding stock performance - Autocar Professional
Is BioAge Labs Inc. a good long term investmentOutperformance with explosive growth - PrintWeekIndia
What drives BioAge Labs Inc. stock pricePhenomenal capital appreciation - Autocar Professional
BioAge Labs Inc. Stock Analysis and ForecastPowerful growth strategies - jammulinksnews.com
BIOA ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by BioAge Labs, Inc. - ACCESS Newswire
Finanzdaten der Bioage Labs Inc-Aktie (BIOA)
Es liegen keine Finanzdaten für Bioage Labs Inc (BIOA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Bioage Labs Inc-Aktie (BIOA) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Pande Vijay Satyanand | Director |
Oct 01 '24 |
Buy |
19.73 |
126,793 |
2,501,626 |
1,026,793 |
Pande Vijay Satyanand | Director |
Oct 02 '24 |
Buy |
19.73 |
67,096 |
1,323,804 |
1,093,889 |
Pande Vijay Satyanand | Director |
Oct 03 '24 |
Buy |
19.90 |
25,306 |
503,589 |
1,119,195 |
Cormorant Asset Management, LP | Former 10% Owner |
Sep 27 '24 |
Buy |
18.00 |
450,000 |
8,100,000 |
1,629,529 |
Pande Vijay Satyanand | Director |
Sep 27 '24 |
Buy |
18.00 |
900,000 |
16,200,000 |
900,000 |
ENRIGHT PATRICK G | Director |
Sep 27 '24 |
Buy |
18.00 |
400,000 |
7,200,000 |
1,710,589 |
HEALY JAMES | Director |
Sep 27 '24 |
Buy |
18.00 |
666,665 |
11,999,970 |
2,227,124 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):